Human Wharton's Jelly Stem Cells Have Unique Transcriptome Profiles Compared to Human Embryonic Stem Cells and Other Mesenchymal Stem Cells

Stem Cell Reviews and Reports

Volumn 7, Issue 1, 2011, Pages 1-16

  Fong, Chui Yee ^a   Chak, Li Ling ^a   Biswas, Arijit ^a   Tan, Jee Hian ^a   Gauthaman, Kalamegam ^a   Chan, Woon Khiong ^a   Bongso, Ariff ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

DNA microarray; Human Wharton's jelly stem cells; Stem cells; Transcriptome

Indexed keywords

EID: 78751641849     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-010-9166-x     Document Type: Article

References (86)

1. Bongso, A., Fong, C. Y., Ng, S. C., & Ratnam, S. (1994). Isolation and culture of inner cell mass cells from human blastocysts. Hum Reprod, 9, 2110-2117.
2. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145-1147.
3. Reubinoff, B. E., Pera, M. F., Fong, C. Y., Trounson, A., & Bongso, A. (2000). Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol, 18, 399-404.
4. Laflamme, M. A., Chen, K. Y., Naumova, A. V., et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol, 25, 1015-1024.
5. Shim, J. H., Kim, S. E., Woo, D. H., et al. (2007). Directed differentiation of human embryonic stem cells towards a pancreatic cell fate. Diabetologia, 50, 1228-1238.
6. Yang, D., Zhang, Z. J., Oldenburg, M., Ayala, M., & Zhang, S. C. (2008). Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells, 26, 55-63.
7. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676.
8. Yu, J., Vodyanik, M. A., Smuga-Otto, K., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917-1920.
9. French, A. J., Adams, C. A., Anderson, L. S., Kitchen, J. R., Hughes, M. R., & Wood, S. H. (2008). Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts. Stem Cells, 26, 485-493.
10. Aleckovic, M., & Simon, C. (2008). Is teratoma formation in stem cell research a characterization tool or a window to developmental biology? Reprod Biomed Online, 17, 270-280.
11. Lensch, M. W., Schlaeger, T. M., Zon, L. I., et al. (2007). Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera. Cell Stem Cell, 1, 253-258.
12. Blum, B., & Benvenisty, N. (2008). The tumorigenecity of human embryonic stem cells. Advances in Cancer Res, 100, 133-158.
13. Bongso, A., Fong, C. Y., & Gauthaman, K. (2008). Taking stem cells to the clinic: major challenges. J Cell Biochem, 105, 1352-1360.
14. Pappa, K. I., & Anagnou, N. P. (2009). Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regen Med, 4, 423-433.
15. Jones, E., & McGonagle, D. (2008). Human bone marrow mesenchymal stem cells in vivo. Rheumatology, 47, 126-131.
16. Fong, C. Y., Richards, M., Manasi, N., Biswas, A., & Bongso, A. (2007). Comparative growth behaviour and characterization of stem cells from human Wharton's jelly. Reprod Biomed Online, 15, 708-718.
17. De Miguel, M. P., Montiel, F. A., Iglesias, P. L., Blazquez Martinez, A. B., & Nistal, M. (2009). Epiblast-derived stem cells in embryonic and adult tissues. Int J Dev Bio, 53, 1529-1540.
18. Karahuseyinoglu, S., Cinar, O., Kilic, E., et al. (2007). Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells, 25, 319-331.
19. Chao, K. C., Chao, K. F., Fu, Y. S., & Liu, S. H. (2008). Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS One, 3, e1451.
20. Wang, L., Tran, I., Seshareddy, K., Weiss, M. L., & Detamore, M. S. (2009). A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering. Tissue Eng Part A, 15, 2259-2266.
21. Sarugaser, R., Lickorish, D., Baksh, D., et al. (2005). Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells, 23, 220-229.
22. Troyer, D. L., & Weiss, M. L. (2008). Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells, 26, 591-599.
23. Weiss, M. L., Medicetty, S., Bledsoe, A. R., et al. (2006). Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells, 24, 781-792.
24. Hou, T., Xu, J., Wu, X., et al. (2009). Umbilical cord Wharton's Jelly: a new potential cell source of mesenchymal stromal cells for bone tissue engineering. Tissue Eng Part A, 15, 2325-2334.
25. Ganta, C., Chiyo, D., Ayuzawa, R., et al. (2009). Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation. Cancer Res, 69, 1815-1820.
26. Ayuzawa, R., Doi, C., Rachakatla, R. S., et al. (2009). Naive human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. Cancer Lett, 280, 31-37.
27. Fong CY, Subramanian A, Biswas A, et al. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells. Reprod BioMed. 2010. Online doi: 10. 1016/j. rbmo. 2010. 04. 010.
28. Reich, M., Liefeld, T., Gould, J., Lerner, J., Tamayo, P., & Mesirov, J. P. (2006). GenePattern 2. 0. Nat Genet, 38, 500-501.
29. Gould, J., Getz, G., Monti, S., Reich, M., & Mesirov, J. P. (2006). Comparative gene marker selection suite. Bioinformatics, 22, 1924-1925.
30. Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B (Methodological), 57, 289-300.
31. Corram, T. E., Settles, M. L., & Chen, X. (2009). Large-scale analysis of antisense transcription in wheat using the Affymetrix GeneChip Wheat Genome Array. BMC Genomics, 10, 253.
32. Maisel, M., Herr, A., Milosevic, J., et al. (2007). Transcription profiling of adult and fetal human neuroprogenitors identifies divergent paths to maintain the neuroprogenitor cell state. Stem Cells, 25, 1231-1240.
33. Subramanian, A., Tamayo, P., Mootha, V. K., et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA, 102, 15545-15550.
34. Cai, J., Chen, J., Liu, Y., et al. (2006). Assessing self-renewal and differentiation in human embryonic stem cell lines. Stem Cells, 24, 516-530.
35. Richards, M., Tan, S. P., Tan, J. H., Chan, W. K., & Bongso, A. (2002). The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells, 22, 51-64.
36. Anzalone, R., Iacono, M. L., Corrao, S., et al. (2009). New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev, 19, 423-438.
37. La Rocca, G., Anzalone, R., Corrao, S., et al. (2009). Isolation and characterization of Oct-4+/HLA-G + mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol, 131, 267-282.
38. Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc, 4, 44-57.
39. The International Stem Cell Initiative. (2007). Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol, 25, 803-816.
40. Nekanti, U., Rao, V. B., Bahirvani, A. G., Jan, M., Totey, S., & Ta, M. (2010). Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells. Stem Cells Dev, 19, 117-30.
41. Alaminos, M., Pérez-Köhler, B., Garzón, I., et al. (2010). Transdifferentiation potentiality of human Wharton's jelly stem cells towards vascular endothelial cells. J Cell Physiol, 223, 640-647.
42. Kim, J. S., Romero, R., Tarca, A. L., et al. (2008). Gene expression profiling demonstrates a novel role for foetal fibrocytes and the umbilical vessels in human fetoplacental development. J Cell Mol Med, 12, 1317-1330.
43. Blum, B., Bar-Nur, O., Golan-Lev, T., & Benvenisty, N. (2009). The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat Biotechnol, 27, 281-287.
44. Muller, F., Laurent, L., Kostka, D., et al. (2008). Regulatory networks define phenotypic classes of human stem cell lines. Nature, 455, 401-405.
45. Chin, M. H., Mason, M. J., Xie, W., et al. (2009). Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell, 5, 111-123.
46. Carlin, R., Davis, D., Weiss, M., Schultz, B., & Troyer, D. (2006). Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod Biol Endocrinol, 4, 8.
47. Jansen BJ, Gilissen C, Roelofs H, et al. Functional differences between mesenchymal stem cell population are reflected by their transcriptome. Stem Cell Dev (in press). 2010.
48. Ben, I., Thomson, M. W., Carey, V. J., et al. (2008). An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet, 40, 499-507.
49. Knoepfler, P. S. (2009). Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells, 27, 1050-1056.
50. Takeda, J., Seino, S., & Bell, G. I. (1992). Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res, 20, 4613-4620.
51. Lee, J., Kim, H. K., Rho, J. Y., Han, Y. M., & Kim, J. (2006). The human OCT-4 isoforms differ in their ability to confer self-renewal. J Biol Chem, 281, 33554-33565.
52. Pain, D., Chirn, G. W., Strassel, C., & Kemp, D. M. (2005). Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identification. J Biol Chem, 280, 6265-6268.
53. Liedtke, S., Stephan, M., & Kogler, G. (2008). Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Biol Chem, 389, 845-850.
54. Niwa, H., Miyazaki, J., & Smith, A. G. (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet, 24, 37237-6.
55. Lengner, C. J., Camargo, F. D., Hochedlinger, K., et al. (2007). Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell, 1, 403-415.
56. Riekstina, U., Cakstina, I., Parfejevs, V., et al. (2009). Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Stem Cell Rev and Rep, 5, 378-386.
57. Greco, S. J., Liu, K., & Rameshwar, P. (2007). Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells, 25, 3143-3154.
58. Liu, T., Wu, Y., Guo, X., Hui, J., Lee, E., & Lim, B. (2008). Effects of ectopic Nanog and Oct4 overexpression on mesenchymal stem cells. Stem Cell Dev, 18, 1013-1022.
59. Guillot, P. V., Gotherstrom, C., Chan, J., Kurata, H., & Fisk, N. M. (2007). Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells, 25, 646-54.
60. Friedman, R., Betancur, M., Boissel, L., Tuncer, H., Cetrulo, C., & Klingemann, H. (2007). Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Biol Blood Marrow Transplant, 13, 1477-1486.
61. Le Blanc, K. (2003). Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy, 5, 485-489.
62. Tse, W. T., Pendleton, J. D., Beyer, W. M., Egalka, M. C., & Guinan, E. C. (2003). Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation, 75, 389-397.
63. Horwitz, E. M., & Dominici, M. (2008). How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy, 10, 771-774.
64. Weiss, M. L., Anderson, C., Medicetty, S., et al. (2008). Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells, 26, 2865-2874.
65. Yoo, K. H., Jang, I. K., Lee, M. W., et al. (2009). Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol, 259, 150-156.
66. Djouad, F., Charbonnier, L. M., Bouffi, C., et al. (2007). Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells, 25, 2025-2032.
67. Rabreau, M., Rouas-Freiss, N., Landi, M., Le Danff, C., & Carosella, E. D. (2000). HLA-G expression in trophoblast cells is independent of embryonic development. Hum Immunol, 61, 1108-1112.
68. Moffett, A., & Loke, Y. W. (2004). The immunological paradox of pregnancy: a reappraisal. Placenta, 25, 1-8.
69. Rouas-Freiss, N., Goncalves, R. M., Menier, C., Dausset, J., & Carosella, E. D. (1997). Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A, 94, 11520-11525.
70. Le Bouteiller, P. (2000). HLA-G in the human placenta: expression and potential functions. Biochem Soc Trans, 28, 208-212.
71. Clark, D. A., Yu, G., Levy, G. A., & Gorczynski, R. M. (2001). Procoagulants in fetus rejection: the role of the OX-2 (CD200) tolerance signal. Semin Immunol, 13, 255-263.
72. Clark, D. A., Keil, A., Chen, Z., Markert, U., Manuel, J., & Gorczynski, R. M. (2003). Placental trophoblast from successful human pregnancies expresses the tolerance signaling molecule, CD200 (OX-2). Am J Reprod Immunol, 50, 187-195.
73. Chamberlain, G., Fox, J., Ashton, B., & Middleton, J. (2007). Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells, 25, 2739-2749.
74. Gorczynski, R. M., Chen, Z., He, W., et al. (2009). Expression of a CD200 transgene is necessary for induction but not maintenance of tolerance to cardiac and skin allografts. J Immunol, 183, 1560-1568.
75. Fong, C. Y., Chak, L. L., Subramanian, A., et al. (2009). A three dimensional anchorage independent in vitro system for the prolonged growth of embryoid bodies to study cancer cell behaviour and anticancer agents. Stem Cell Rev Rep, 5, 410-419.
76. Moser, B., Wolf, M., Walz, A., & Loetscher, P. (2004). Chemokines: multiple levels of leukocyte migration control. Trends Immunol, 25, 75-84.
77. Kobayashi, M., Fitz, L., Ryan, M., et al. (1989). Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med, 170, 827-845.
78. Wolf, S. F., Temple, P. A., Kobayashi, M., et al. (1991). Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol, 146, 3074-3081.
79. Colombo, M. P., & Trinchieri, G. (2002). Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev, 13, 155-168.
80. Weiss, J. M., Subleski, J. J., Wigginton, J. M., & Wiltrout, R. H. (2007). Immunotherapy of cancer by IL-12-based cytokine combinations. Expert Opin Biol Ther, 7, 1705-1721.
81. Herman, J. G., & Meadows, G. G. (2007). Increased class 3 semaphorin expression modulates the invasive and adhesive properties of prostate cancer cells. Int J Oncol, 30, 1231-1238.
82. Esselens, C., Malapeira, J., Colomé, N., et al. (2010). The cleavage of semaphorin 3C induced by ADAMTS1 promotes cell migration. J Biol Chem, 285, 2463-2473.
83. Capparuccia, L., & Tamagnone, L. (2009). Semaphorin signaling in cancer cells and in cells of the tumor microenvironment-two sides of a coin. J Cell Sci, 122, 1723-1736.
84. Tamm, I., Wang, Y., Sausville, E., et al. (1998). IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res, 58, 5315-5320.
85. Baker, D. E., Harrison, N. J., Maltby, E., et al. (2007). Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol, 25, 207-215.
86. Angelucci, S., Marchisio, M., Di Giuseppe, F., et al. (2010). Proteome analysis of human Wharton's jelly cells during in vitro expansion. Proteome Science, 8, 18-25.